Resources from the same session
1214O - Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)
Presenter: Marie Wislez
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1215O - Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): results from the phase II PRINCEPS trial.
Presenter: Benjamin Besse
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA84 - Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial
Presenter: Solange Peters
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1783O - Patient reported outcomes from a randomized phase II trial comparing standard-dose with high-dose twice daily (BID) thoracic radiotherapy (TRT) in limited stage small cell lung cancer (LS SCLC)
Presenter: Bjorn Gronberg
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Q&A and live discussion
Presenter: Lyudmila Bazhenova
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Webcast
Invited Discussant LBA84 and 1783O
Presenter: Corinne Faivre-Finn
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lyudmila Bazhenova
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Webcast